Red Electrica Corporacion SA (0RI5)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 14.59 |
|---|---|
| 52-week range | 13.54 – 16.94 |
| Return, 1 month / 3 months | −4.4% / −6.3% |
| Return, 1 year / 3 years | −9.9% / +9.8% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 17.1% |
| Worst drawdown (1 year) | -14.3% |
| Average daily value traded | 3.88M EUR |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Red Electrica Corporacion operates the high-voltage electricity transmission network in Spain, moving power from generators to the regional distribution systems and large industrial users. The company is based in Madrid and manages the interconnections that link the Spanish grid with neighbouring countries, helping balance supply across borders. It also provides related services for the operation of the electricity system, including coordination of generation and demand in real time.
On this site Red Electrica Corporacion SA appears as a stock on the London Exchange (UK), code 0RI5, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Red Electrica Corporacion SA (0RI5) trades on the London Exchange in UK. It last closed at EUR 14.59 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,159 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.9% and over the last three months it fell 6.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.3% | ||
| From 52-week high | -9.3% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.3% | ||
| 6-month return | 1.0% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.3% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.88M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −4.4% |
| 3 months | −6.3% |
| 6 months | +1.0% |
| 1 year | −9.9% |
| 3 years | +9.8% |
| 5 years | +3.9% |
Signals
| 50-day / 200-day average | 14.99 / 14.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.4860 |
| 5 Jan 2026 | EUR 0.1620 |
| 4 Jul 2025 | EUR 0.4860 |
| 3 Jan 2025 | EUR 0.1620 |
| 27 Jun 2024 | EUR 0.5891 |
| 3 Jan 2024 | EUR 0.2209 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.